Sepracor kicks off early trials of depression-fighting drug (bizjournals.com via Yahoo! Finance)Sepracor
Sepracor kicks off early trials of depression-fighting drug (bizjournals.com via Yahoo! Finance)
Sepracor Inc. has launched an early-stage human clinical trial to test a potential treatment for depression.
Repligen and The Stanley Medical Research Institute Expand Development Agreement for Uridine for Bipolar Depression (PR Newswire via Yahoo! Finance)
Repligen Corporation today announced that the Company has entered into an expanded development agreement with the Stanley Medical Research Institute under which Repligen will receive approximately $1,000,000 in funding for a Phase 2 clinical trial of uridine in bipolar depression.
Depression can hit teens — and young children — just as it hits adults (The Daily Item)
COLUMBIA, S.C. — Looking back now, she realizes that being in a ticky-tacky Tennessee vacation spot probably had nothing to do with her urge to self-destruct.
Cavett lifts spirits with tales of his own frailties (Omaha World-Herald)
Dick Cavett's experience with depression was why he was the featured speaker Thursday night at the ninth annual "Breaking the Silence" dinner, held by the Community Alliance. The nonprofit organization provides support, housing and treatment services for mentally ill people.
AstraZeneca says data support new Seroquel use (Reuters via Yahoo! News)
Anglo-Swedish drugmaker AstraZeneca Plc said on Friday new clinical trial data underlined the potential of its schizophrenia drug Seroquel as a treatment for bipolar disorder, a form of manic depression.
